The FDA approved Dendreon's immunotherapy Provenge for the treatment of certain men with advanced prostate cancer, marking the first approval of a vaccine to treat cancer. Karen Midthun, acting director of the FDA’s Center for Biologics Evaluation and Research said the autologous cellular immunotherapy "provides a new treatment option for men with advanced prostate cancer, who currently have limited effective therapies available.”
Source
Showing posts with label prostate cancer. Show all posts
Showing posts with label prostate cancer. Show all posts
Thursday, April 29, 2010
Subscribe to:
Posts (Atom)
Posts
